bencyclane has been researched along with HbS Disease in 1 studies
Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bencyclane appears to be a promising anti-sickling agent that can be used orally in SCD." | 1.29 | Bencyclane as an anti-sickling agent. ( Aikimbaev, KS; Başlamişli, F; Güvenç, B; Isbir, T; Koçak, R; Tamer, L, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koçak, R | 1 |
| Başlamişli, F | 1 |
| Güvenç, B | 1 |
| Tamer, L | 1 |
| Aikimbaev, KS | 1 |
| Isbir, T | 1 |
1 other study available for bencyclane and HbS Disease
| Article | Year |
|---|---|
Bencyclane as an anti-sickling agent.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Bencyclane; Ca(2+) Mg(2+)-ATPase; Calci | 1996 |